One plan - full access

No subscription, no auto-renewal, no hidden terms.
Pay once and use it for 30 days.

PRO plan No auto-renewal
$18

30 days of full access
One-time payment

🌐 US & Global Companies
Get access for 30 days →
♧ Secure payment · Instant access

What is included

  • ✓Full access to detailed company analysis
  • ✓Fundamental screener
  • ✓Advanced stock screener filters
  • ✓5 ratings. Separate lists for US & Global Companies and MOEX
  • ✓Company data export in XLSX and CSV
  • ✓MarketCap’s overall ranking of top companies
  • ✓Analytics updates after each new financial report
⚠ The service is not an investment advisor. Financial statement data from public companies is available to everyone - MarketCap structures and analyzes it.
Spectrum Brands Holdings logo
Spectrum Brands Holdings SPB
$ 78.96 -0.7%
report update icon

Quarterly report 2026-Q3
added 08-07-2026

Spectrum Brands Holdings Financial Ratios 2025-2009 | SPB

Brief overview of Spectrum Brands Holdings's valuation multiples

Current figures are compared with the company's own five-year history for 2021–2025.

Key multiples at the end of the period are P/E 14.17x (median 21.56x), EV/EBITDA 12.39x (median 14.77x), P/S 0.5x (median 0.9x). The current ratio basket stands about 40.6% below the five-year comparison base. Earnings and risk trends should explain the discount.

The inverse P/E implies an earnings yield of 7.1%. This is not a dividend yield, but current earnings relative to market price.

Current measures of operating quality are ROE 5.2%, ROA 3%, ROCE 6.5%. Efficiency ratios are restrained, with capital and assets producing modest returns.

The time from paying for inputs to receiving cash rose from 45.6 days to 98.5 days. Cash turnover slowed.

Valuation takeaway

Spectrum Brands Holdings's discount may reflect genuine profitability issues rather than market inefficiency alone.

Annual Financial Ratios Spectrum Brands Holdings

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009

P/E

14.2 21.6 1.5 27.8 22.7 34.7 5.4 3.1 29.7 -14.9 -4.7 -205.7 -33.1 13.3 20.5 -35.0 -

P/S

0.5 0.9 0.9 0.6 1.4 1.3 0.7 0.8 0.6 0.6 0.5 0.4 0.3 0.3 0.2 6.2 -

EPS

3.9 4.1 45.6 1.8 4.4 2.2 9.8 20.8 3.3 -6.2 -2.8 -0.5 -0.7 0.1 0.1 -0.1 -

EV (Enterprise Value)

2.76 B 4.02 B 4.61 B 6.26 B 7.98 B 6.56 B 5.45 B 8 B 36.8 B 36.5 B 32.7 B 29.3 B 26.1 B 23 B 21.8 B 7.89 B -97.8 M

EBITDA per Share

8.67 8.99 -2.9 3 5.01 2.76 9.65 11.9 22.3 23.5 18.2 31.8 46.7 31.1 11.1 1.38 -

EV/EBITDA

12.4 14.8 -40.3 51.1 37.1 8.6 8.7 14.8 12.1 10.5 13.6 7.2 4.3 2.7 10.3 43.3 -

PEG

-0.12 -0.17 -0.03 -1.45 -1.87 -1.54 -0.1 0.01 0.19 -0.23 0.01 -8.61 0.16 0.02 0.19 - -

P/B

0.7 1.3 1.0 1.6 2.9 2.4 1.5 1.5 4.2 4.6 4.5 1.5 1.4 0.8 0.8 4.5 -

P/CF

7.0 16.5 -6.4 -37.0 14.9 11.7 -44.6 8.6 4.3 3.6 15.8 4.2 3.6 2.1 4.7 103.7 -

ROE %

5.23 5.83 71.56 5.67 12.82 6.91 27.79 48.59 13.98 -31.15 -94.90 -0.71 -4.34 5.98 3.92 -21.64 -

ROA %

2.96 3.25 34.26 1.24 3.55 1.91 9.02 9.92 0.30 -0.56 -1.72 -0.03 -0.16 0.36 0.15 -3.78 -

ROCE %

6.54 7.97 -8.17 1.84 6.57 0.61 7.54 4.83 1.49 1.89 1.44 2.25 2.95 2.18 1.03 9.22 -

Current Ratio

2.3 2.3 1.9 1.3 1.4 1.4 1.5 2.5 1.2 3.0 17.6 18.2 16.8 27.9 2.5 1.4 -

DSO

75.2 68.5 45.3 28.9 45.6 59.7 41.4 33.6 41.5 154.4 39.7 35.8 40.3 33.8 41.4 - -

DIO

93.3 91.0 113.8 114.5 - - 80.2 92.2 90.4 86.6 90.9 78.7 84.3 77.3 77.1 - -

DPO

69.9 78.1 77.7 71.7 - - 66.8 79.9 85.0 68.3 74.8 66.4 70.7 55.7 58.3 - -

Operating Cycle

168.4 159.5 159.1 143.3 45.6 59.7 121.6 125.9 131.9 241.1 130.6 114.5 124.6 111.1 118.5 - -

Cash Conversion Cycle

98.5 81.4 81.3 71.6 45.6 59.7 54.8 46.0 46.9 172.8 55.8 48.1 53.9 55.4 60.2 - -

All numbers in USD currency

Quarterly Financial Ratios Spectrum Brands Holdings

2026-Q3 2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-1.16 0.95 1.21 1.21 0.8 0.8 0.03 0.84 0.21 0.21 2.03 0.85 46.07 46.07 -1.31 -0.51 1.39 0.8 0.39 1.68 3.27 0.72 0.86 - 1.05 3.37 -1.26 -0.75 -1.97 -0.53 -0.75 -2.11 -2.32 12.39 -2.11 15.69 -0.81 0.07 2.53 6.57 -0.04 -0.67 1.06 -0.18 -0.73 -0.38 -0.17 -0.56 -0.03 0.28 -0.56 -0.28 -1.45 0.45 -0.28 0.31 0.79 -1.07 0.31 0.12 -0.77 1.16 -0.45

EBITDA per Share

1.76 2.92 2.26 2.26 1.84 1.84 1.28 2.48 2.14 2.14 2.99 1.16 -2.79 -2.79 -1.59 -0.2 1.06 1.25 0.1 1.23 3.29 1 1.77 - 5.07 3.01 2.31 -0.09 5.81 2.64 -0.09 1.71 8.81 4.12 1.7 2.78 10.3 4.14 0.3 0.36 2.55 1.17 0.7 0.62 0.77 -0.05 0.33 -0.93 1.57 1.68 -0.76 1.51 1.93 1.55 1.51 1.63 1.07 0.72 1.63 - -0.07 1.03 -

ROE %

2.70 5.20 5.09 3.64 3.31 2.55 1.79 4.45 4.56 76.93 149.26 142.01 139.06 70.90 0.76 6.50 13.21 18.18 17.72 19.01 17.22 18.06 11.98 9.49 7.05 -1.74 -13.57 -11.64 -17.24 -19.01 8.17 3.16 73.06 76.91 51.54 125.59 102.46 104.79 83.68 50.00 2.61 -20.63 -12.69 -51.72 -51.66 -27.54 -7.84 -9.68 -5.53 9.05 16.52 20.44 30.98 9.59 -16.18 -6.19 2.83 34.20 38.69 32.40 15.11 24.27 -6.97

ROA %

1.55 2.86 2.78 1.98 1.80 1.40 1.00 1.58 30.18 59.28 59.12 58.19 57.21 28.94 0.22 1.41 3.18 4.81 4.83 5.26 4.75 4.98 3.30 2.62 1.91 -0.81 -4.14 -3.71 -4.49 -4.15 1.54 0.78 7.86 9.27 4.08 6.94 1.94 1.99 1.62 0.79 0.10 -0.28 -0.13 -0.82 -1.07 -0.68 -0.14 -0.40 -0.14 0.24 0.28 0.55 0.92 0.22 -0.69 -0.30 -0.00 1.25 1.53 1.23 0.57 0.92 -0.26

ROCE %

6.00 6.80 6.16 5.77 6.54 7.18 7.81 10.14 9.02 1.86 -5.30 -15.17 -17.89 -12.48 -4.66 1.24 4.67 11.01 10.04 13.73 20.21 20.07 22.89 19.82 16.68 17.69 16.43 8.92 13.86 16.56 17.84 22.12 26.57 45.87 52.40 54.34 55.62 92.97 109.16 124.10 142.09 82.77 40.59 28.17 -14.20 -13.48 15.11 -3.60 43.03 61.32 70.63 108.06 95.99 77.86 59.58 53.13 30.52 33.75 29.37 11.08 -4.91 13.46 2.53

Current Ratio

2.1 2.2 2.2 2.2 2.1 2.1 2.1 2.3 2.2 2.2 - 1.9 1.7 1.7 1.3 1.3 1.3 1.3 1.3 1.4 1.4 1.4 1.4 - 1.4 1.4 1.4 1.4 1.5 1.5 1.5 1.2 1.3 1.3 1.3 1.2 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.0 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.1 - 1.1 1.1 1.1

DSO

69.1 69.3 69.7 75.6 78.8 77.5 81.0 80.4 72.5 36.2 34.0 59.7 46.0 42.0 37.8 34.9 10.6 36.6 52.3 51.1 14.8 44.6 14.9 - 31.2 46.5 75.8 68.9 32.8 31.8 38.8 37.9 29.7 29.0 32.1 26.9 53.7 49.0 49.6 83.0 68.5 55.9 69.2 94.4 45.1 48.0 52.8 51.3 35.3 33.4 41.9 38.0 37.2 39.5 38.1 36.6 31.6 37.4 17.1 15.4 20.2 - -

DIO

117.6 97.6 94.5 100.4 106.3 110.0 113.4 97.7 84.2 42.1 46.8 100.5 - 107.6 - 127.5 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

84.5 71.0 70.0 70.4 70.7 73.5 78.4 75.4 70.7 35.4 39.2 86.0 - 92.5 - 71.4 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

- - - 176.0 - 187.6 194.4 178.1 - - - 160.2 - 149.6 37.8 162.4 10.6 36.6 52.3 51.1 14.8 44.6 14.9 - 31.2 46.5 75.8 68.9 32.8 31.8 38.8 37.9 29.7 29.0 32.1 26.9 53.7 49.0 49.6 83.0 68.5 55.9 69.2 94.4 45.1 48.0 52.8 51.3 35.3 33.4 41.9 38.0 37.2 39.5 38.1 36.6 31.6 37.4 17.1 15.4 20.2 - -

Cash Conversion Cycle

- - - 105.6 - 114.1 116.1 102.7 - - - 74.2 - 57.1 37.8 91.0 10.6 36.6 52.3 51.1 14.8 44.6 14.9 - 31.2 46.5 75.8 68.9 32.8 31.8 38.8 37.9 29.7 29.0 32.1 26.9 53.7 49.0 49.6 83.0 68.5 55.9 69.2 94.4 45.1 48.0 52.8 51.3 35.3 33.4 41.9 38.0 37.2 39.5 38.1 36.6 31.6 37.4 17.1 15.4 20.2 - -

All numbers in USD currency

Multiples are an important financial analysis tool for the company Spectrum Brands Holdings, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.

Advantages of Using Financial Ratios
  • Simplified Data Analysis
    Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition.
  • Comparability Between Companies
    Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations.
  • Identification of Trends and Issues
    Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks.
  • Decision Support
    Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions.
  • Accelerated Assessment of Investment Attractiveness
    Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.

Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.

Financial Ratios of other stocks in the Household products industry

Issuer Price % 24h Market Cap Country
Coty Coty
COTY
$ 3.05 -5.13 % $ 2.68 B usaUSA
Dogness (International) Corporation Dogness (International) Corporation
DOGZ
$ 0.77 5.11 % $ 13.7 M chinaChina
e.l.f. Beauty e.l.f. Beauty
ELF
$ 113.78 -0.84 % $ 6.63 B usaUSA
Edgewell Personal Care Company Edgewell Personal Care Company
EPC
$ 26.98 -4.39 % $ 1.28 B usaUSA
Acme United Corporation Acme United Corporation
ACU
$ 63.2 -0.6 % $ 239 M usaUSA
Revlon Revlon
REV
- -4.41 % $ 212 M usaUSA
Mannatech, Incorporated Mannatech, Incorporated
MTEX
$ 8.51 4.29 % $ 16.2 M usaUSA
Colgate-Palmolive Company Colgate-Palmolive Company
CL
$ 93.4 -1.21 % $ 75.5 B usaUSA
Nature's Sunshine Products Nature's Sunshine Products
NATR
$ 12.26 -3.54 % $ 221 M usaUSA
Nu Skin Enterprises Nu Skin Enterprises
NUS
$ 4.76 -4.51 % $ 235 M usaUSA
Newell Brands Newell Brands
NWL
$ 5.56 -2.11 % $ 2.33 B usaUSA
Church & Dwight Co. Church & Dwight Co.
CHD
$ 105.0 -0.91 % $ 25.5 B usaUSA
The Procter & Gamble Company The Procter & Gamble Company
PG
$ 156.84 -1.61 % $ 366 B usaUSA
The Estée Lauder Companies The Estée Lauder Companies
EL
$ 103.66 -2.32 % $ 37.6 B usaUSA
United-Guardian United-Guardian
UG
$ 6.75 -0.15 % $ 31 M usaUSA
Unilever PLC Unilever PLC
UL
$ 64.4 -1.26 % $ 141 B britainBritain
Hims & Hers Health Hims & Hers Health
HIMS
$ 29.21 -0.31 % $ 6.57 B usaUSA
LifeVantage Corporation LifeVantage Corporation
LFVN
$ 5.95 -0.34 % $ 74.6 M usaUSA
Inter Parfums Inter Parfums
IPAR
$ 113.2 -2.33 % $ 3.63 B usaUSA
Helen of Troy Limited Helen of Troy Limited
HELE
$ 28.38 -3.54 % $ 653 M bermudaBermuda
The Clorox Company The Clorox Company
CLX
$ 84.77 -3.05 % $ 10.5 B usaUSA
Kimberly-Clark Corporation Kimberly-Clark Corporation
KMB
$ 106.64 -1.56 % $ 35.4 B usaUSA
Natura &Co Holding S.A. Natura &Co Holding S.A.
NTCO
- - $ 9.02 B -
USANA Health Sciences USANA Health Sciences
USNA
$ 14.22 -3.4 % $ 264 M usaUSA